Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

61.80
+6.4011.55%
Post-market: 61.950.1500+0.24%19:59 EDT
Volume:12.45M
Turnover:747.24M
Market Cap:24.41B
PE:-7.59
High:62.30
Open:56.21
Low:54.51
Close:55.40
52wk High:62.30
52wk Low:22.28
Shares:394.94M
Float Shares:363.29M
Volume Ratio:1.78
T/O Rate:3.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.1400
EPS(LYR):-7.2600
ROE:-36.56%
ROA:-13.09%
PB:3.29
PE(LYR):-8.51

Loading ...

Moderna President Stephen Hoge reports sale of 53,336 common shares valued at $2.74 million

Reuters
·
4 hours ago

ETF Daily | EOSU Jumps 23%; MRNX Climbs 19%; ROBN, HODU Surge 18%; China Shorts and Gold Bears Outperform

ETF Tracker
·
30 mins ago

Sector Update: Healthcare Stocks Decline Wednesday Afternoon

MT Newswires Live
·
7 hours ago

Movement Alert|Moderna Rises 5.09% in Regular Trading, Cancer Prevention mRNA Vaccine Receives UK Clinical Trial Approval

Market Focus
·
Yesterday

Stock Track | Moderna Soars 5.02% Intraday on Expansion Plans for German Production Facilities

Stock Track
·
Yesterday

Moderna to host Investor Event - Science Day webcast

Reuters
·
Yesterday

Market Chatter: Moderna Looking to Invest in German Production Sites

MT Newswires Live
·
Yesterday

Moderna Interested in Production Facilities in Germany, Particularly BioNTech Plants, Handelsblatt Reports

THOMSON REUTERS
·
Yesterday

Moderna Inc. Stock Climbs 6.3%, Outperforms Peers

Dow Jones
·
Yesterday

Moderna Shares Gain 8.6% After US FDA Says Co Flu Shot Data May Support Use in Older Adults

THOMSON REUTERS
·
Yesterday

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
Yesterday

Stock Track | Moderna Soars 5.08% Intraday on FDA Staff's Positive Flu Vaccine Assessment

Stock Track
·
Jun 16

Movement Alert|Moderna Rises 5.81% in Regular Trading, Organizational Restructuring Paves Way for Multiple New Product Launches

Market Focus
·
Jun 16

Moderna flu vaccine briefing docs ‘read favorably,’ says Jefferies

TIPRANKS
·
Jun 16

US FDA staff says data may support effectiveness of Moderna's flu vaccine in older adults

Reuters
·
Jun 16

Cepi CEO: Oxford and Moderna Lead Candidates Could Enter Phase 1 Trials as Early as July

THOMSON REUTERS
·
Jun 16

Moderna Overhauls Leadership Ahead of Product Launches

Dow Jones
·
Jun 16

FDA Staff Says Preliminary Assessment Is That Moderna's Flu Shot Data May Support Effectiveness in Adults 65 and Older -Document

THOMSON REUTERS
·
Jun 16

Moderna Organizational Changes To Prepare For Multiple Product Launches In 2027 And 2028

Reuters
·
Jun 16

Moderna announces executive changes ahead of potential launches

Reuters
·
Jun 16